12月4日，广东宏大盘中下跌2.02%，截至11:09，报37.88元/股，成交1.88亿元，换手率0.74%，总市值 287.89亿元。 资金流向方面，主力资金净流出1046.24万元，特大单买入185.96万元，占比0.99%，卖出1137.46万元， 占比6.06%；大单买入4176.52万元，占比22.26%，卖出4271.27万元，占比22.76%。 广东宏大今年以来股价涨46.62%，近5个交易日跌3.61%，近20日跌4.25%，近60日涨15.69%。 广东宏大所属申万行业为：基础化工-化学制品-民爆制品。所属概念板块包括：军民融合、航天军工、 基金重仓、融资融券、并购重组等。 截至11月20日，广东宏大股东户数2.67万，较上期增加6.92%；人均流通股24731股，较上期减少 6.48%。2025年1月-9月，广东宏大实现营业收入145.52亿元，同比增长56.95%；归母净利润6.53亿元， 同比增长0.54%。 分红方面，广东宏大A股上市后累计派现22.48亿元。近三年，累计派现12.88亿元。 机构持仓方面，截止2025年9月30日，广东宏大十大流通股东中，香港中央结算有限公司位居第 ...

"跨境理财通"是大湾区推动金融市场互联互通的重要机制之一。记者从广东证监局获悉，截至2025年9月末，粤港澳大湾区参与"跨境理财通"个人投资者 16.98万人，包括港澳投资者5.37万人，内地投资者11.61万人；"跨境理财通"投资者人数较券商试点前增长34.4%，特别是内地投资者增长57.3%。"跨境理 财通"的落地，有力地推动了金融高水平开放。 金融枢纽的建设离不开强大的金融机构。截至2025年9月底，广东辖区证券公司净资本达1393.6亿元，总资产规模1.01万亿元，净资产规模1805.75亿元， 分别较2020年末增长33.13%、90.83%和43.06%。"十四五"时期，广东辖区金融机构整体综合实力显著增强。 着力推进投顾业态发展，是广东落实资本市场投资端改革的关键环节，也是推动行业机构加快财富管理转型的重要举措。2023年，广东证监局支持广州市 推动设立广州投资顾问学院、广州投资顾问研究院、广州投顾产业链投资公司三家机构，累计为全国129家证券、基金、银行、独立销售等机构提供转型 赋能服务。 广东是我国经济第一大省，也是资本市场最为活跃的地区之一。"十四五"时期，广东辖区（不含深圳，下同）资本市 ...

截至11月20日，广东宏大股东户数2.67万，较上期增加6.92%；人均流通股24731股，较上期减少 6.48%。2025年1月-9月，广东宏大实现营业收入145.52亿元，同比增长56.95%；归母净利润6.53亿元， 同比增长0.54%。 分红方面，广东宏大A股上市后累计派现22.48亿元。近三年，累计派现12.88亿元。 机构持仓方面，截止2025年9月30日，广东宏大十大流通股东中，香港中央结算有限公司位居第三大流 通股东，持股1166.84万股，为新进股东。广发小盘成长混合(LOF)A（162703）位居第六大流通股东， 持股861.50万股，相比上期增加64.32万股。广发中小盘精选混合A（005598）位居第七大流通股东，持 股789.51万股，相比上期增加66.07万股。广发价值核心混合A（010377）位居第八大流通股东，持股 718.77万股，为新进股东。鹏华中证细分化工产业主题ETF联接A（014942）位居第九大流通股东，持 股681.67万股，为新进股东。南方中证500ETF（510500）位居第十大流通股东，持股666.30万股，为新 进股东。富国天惠成长混合(LOF)A/B（1 ...

化工板块今日（11月26日）震荡盘整。反映化工板块整体走势的化工ETF（516020）早盘持续低位震荡，随后有所拉升，截至发稿，场内价格涨 0.13%。 成份股方面，民爆制品、钾肥、磷化工等板块部分个股涨幅居前。截至发稿，广东宏大大涨超4%，亚钾国际、盐湖股份双双涨超3%，宏达股份、扬农 化工、藏格矿业等多股跟涨超1%。 | 分时 多日 | | 1分 5分 15分 30分 60分 | | 日 12 | | | F9 盘前盘后 餐加 九转 画线 工具 | 6 2 > | 化. | 1 | 516020 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 0.781 | | | 13:22 价 0.777 | | | : 0.001(0.13%) 均价 0.774 成交量 256 IOPV 0.7774 | | 0.6699 | 0 -7 | | +0.001 +0.13% | | 0.779 | | | | | | | | 0.33% | SSE CNY | 13:22:37 交易中 | 十八郎 之 版 | ...

11月26日，广东宏大涨5.02%，截至发稿，报40.39元/股，成交5.26亿元，换手率2.01%，总市值306.96 亿元。 资料显示，广东宏大控股集团股份有限公司位于广东省广州市天河区兴民路222号之三(C3栋)天盈广场 东塔56层，成立日期1988年5月14日，上市日期2012年6月12日，公司主营业务涉及民爆器材产品(含现 场混装)、矿山基建剥离、整体爆破方案设计、爆破开采、矿物分装与运输等服务。主营业务收入构成 为：露天矿山开采58.54%，工业炸药12.43%，地下矿山开采11.82%，化工产品10.47%，起爆器材 2.68%，液化天然气2.39%，防务装备0.88%，其他0.80%。 从基金十大重仓股角度 数据显示，中邮基金旗下1只基金重仓广东宏大。中邮军民融合灵活配置混合A（004139）三季度持有 股数56万股，占基金净值比例为2.3%，位居第九大重仓股。根据测算，今日浮盈赚取约108.08万元。 中邮军民融合灵活配置混合A（004139）成立日期2017年4月1日，最新规模8.59亿。今年以来收益 29.07%，同类排名2414/8134；近一年收益25.46%，同类排名3082/80 ...

交易所数据显示，11月24日，广东宏大收盘38.23元，上涨2.08%，滚动市盈率PE（当前股价与前四季度 每股收益总和的比值）达到32.24倍，总市值290.55亿元。 从行业市盈率排名来看，公司所处的采掘行业行业市盈率平均35.18倍，行业中值50.34倍，广东宏大排 名第10位。 来源：市场资讯 广东宏大控股集团股份有限公司的主营业务是矿山工程服务、民用爆破器材生产与销售、防务装备，以 及能化产品生产与销售。公司的主要产品是矿山基建剥离、民用爆破器材产品（含现场混装）、矿井建 设、整体爆破方案设计、爆破开采、矿物分装与运输、导弹武器系统、精确制导弹药、硝酸铵、化肥尿 素、三聚氰胺。 最新一期业绩显示，2025年三季报，公司实现营业收入145.52亿元，同比增加55.92%；净利润6.53亿 元，同比增加0.54%，销售毛利率19.94%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)6广东宏大32.2432.364.36290.55亿行业平均 35.1833.774.33157.53亿行业中值50.3442.503.6054.49亿1海油发展10.0010.451.34382.21亿2海油工程 ...

资料显示，广东宏大控股集团股份有限公司位于广东省广州市天河区兴民路222号之三(C3栋)天盈广场 东塔56层，成立日期1988年5月14日，上市日期2012年6月12日，公司主营业务涉及民爆器材产品(含现 场混装)、矿山基建剥离、整体爆破方案设计、爆破开采、矿物分装与运输等服务。主营业务收入构成 为：露天矿山开采58.54%，工业炸药12.43%，地下矿山开采11.82%，化工产品10.47%，起爆器材 2.68%，液化天然气2.39%，防务装备0.88%，其他0.80%。 11月20日，广东宏大跌6.38%，成交额7.37亿元。两融数据显示，当日广东宏大获融资买入额7501.11万 元，融资偿还5990.83万元，融资净买入1510.28万元。截至11月20日，广东宏大融资融券余额合计8.18 亿元。 融资方面，广东宏大当日融资买入7501.11万元。当前融资余额8.08亿元，占流通市值的2.82%，融资余 额超过近一年90%分位水平，处于高位。 融券方面，广东宏大11月20日融券偿还4300.00股，融券卖出2.68万股，按当日收盘价计算，卖出金额 102.62万元；融券余量25.10万股，融券余额961 ...

Investment Rating - The report maintains an investment rating of "Outperform the Market - A" for the industry [5]. Core Insights - The civil explosives industry is experiencing a stabilization in scale, with effective integration and optimization of supply-side dynamics. The industry is projected to have a production value of 41.695 billion yuan in 2024, a year-on-year decrease of 4.50%, while the total sales value is expected to be 41.142 billion yuan, down 5.26%. However, the total profit is anticipated to grow to 9.639 billion yuan, reflecting a year-on-year increase of 13.04% [1][3][23]. Summary by Sections 1. Industry Scale and Policy Integration - The civil explosives industry is gradually stabilizing, with policies promoting integrated operations in production and blasting services. The main raw material, ammonium nitrate, remains at a low price, supporting the industry's profitability [14][19]. - The industry has seen a compound annual growth rate (CAGR) of 8.17% in production value from 2016 to 2023, with a significant increase in blasting service revenue from 8.061 billion yuan in 2016 to 35.311 billion yuan in 2024, representing a CAGR of 20.28% [1][29]. 2. Supply-Side Optimization and Industry Concentration - The civil explosives industry is undergoing significant consolidation, with the number of production enterprises decreasing from over 400 in 2005 to fewer than 50 by 2025. The top 10 enterprises' production value share has increased from 41% in 2018 to 62.47% in 2024 [2][42]. - The industry is characterized by a shift in production capacity towards the central and western regions of China, driven by demand from mining and infrastructure projects [2][3]. 3. Mining Investment Growth and Regional Demand - Investment in the mining sector is on the rise, particularly in Xinjiang and Tibet, where the demand for civil explosives is expected to increase due to ongoing coal and metal mining projects. The fixed asset investment growth in these regions is among the highest in the country [3][8]. - The civil explosives industry is projected to benefit from the ongoing construction of major infrastructure projects, such as the Yajiang Hydropower Station and the New Tibet Railway, which are expected to drive demand for explosives [3][8]. 4. Key Investment Targets - The report highlights key companies in the civil explosives sector, including Guangdong Hongda, Yipuli, Xuefeng Technology, and Gaozheng Explosives, which are well-positioned to benefit from regional demand growth and industry consolidation [8][4].

Core Viewpoint - The company has shown strong revenue growth in the first three quarters of 2025, with a significant increase in operating income, while net profit remained stable, indicating resilience in its financial performance despite challenges in cash flow [2][3]. Financial Performance - The company achieved operating revenue of 14.552 billion, a year-on-year increase of 55.92% [2]. - The net profit attributable to shareholders was 653 million, remaining roughly flat compared to the previous year [2]. - Cash flow from operating activities was -236 million, down from 189 million in the same period last year [2]. Business Segments - The mining service segment is expanding, focusing on key domestic markets such as Xinjiang, Tibet, and Inner Mongolia, while also pursuing opportunities along the Belt and Road Initiative with a backlog of over 35 billion in orders [3][6]. - The civil explosives segment has increased its production capacity to 725,500 tons, maintaining stable business scale amid industry consolidation [3][12]. - The defense equipment segment is performing well, with recent acquisitions and ongoing military trade projects, reflecting the company's commitment to transitioning towards military applications [3][10]. Strategic Plans - The company plans to enhance operational efficiency and market competitiveness through internal management improvements [5]. - There is a strong focus on expanding the mining service segment in Xinjiang, with significant investments in resources and capabilities [7]. - The company is committed to achieving a target of one million tons in civil explosives capacity and is actively pursuing mergers and acquisitions in this sector [10]. - The defense equipment segment is expected to grow, with ongoing investments in high-end intelligent weapon systems and related supply chain enhancements [10][12]. Future Outlook - The company maintains confidence in its growth trajectory, particularly in the mining service and defense sectors, with a strategic emphasis on international expansion and large-scale projects [6][9][12].

Group 1 - On November 17, a total of 12 companies were investigated by institutions, with 6 companies being focused on by funds, including Fuxiang Pharmaceutical, Lingzhi Software, and Fengyuan Co., Ltd. [1] - Fuxiang Pharmaceutical received the most attention, with 12 funds participating in its investigation, while Lingzhi Software and Fengyuan Co., Ltd. had 11 and 5 funds involved, respectively [1][2] - Among the companies investigated, there were 3 from the Shenzhen Main Board, 2 from the ChiNext Board, and 1 from the Sci-Tech Innovation Board [1] Group 2 - In terms of total market capitalization, 2 companies had a market value of less than 10 billion yuan, namely Lingzhi Software and Fengyuan Co., Ltd. [2] - Over the past 5 days, 4 of the investigated stocks increased in value, with Fuxiang Pharmaceutical and Fengyuan Co., Ltd. showing significant gains of 56.90% and 33.24%, respectively [2] - The stocks that experienced declines included Lingzhi Software and Huali Chuantong, with declines of 14.86% and 3.13%, respectively [2][3] Group 3 - The latest closing prices and 5-day price changes for the investigated companies are as follows: Fuxiang Pharmaceutical at 21.15 yuan (+56.90%), Lingzhi Software at 15.13 yuan (-14.86%), Fengyuan Co., Ltd. at 23.85 yuan (+33.24%), and Shiji Information at 10.03 yuan (+7.16%) [3] - The highest net inflow of funds over the past 5 days was seen in Fengyuan Co., Ltd. with 450 million yuan, followed by Guangdong Hongda and Shiji Information with net inflows of 186 million yuan and 94.91 million yuan, respectively [2]